Results 91 to 100 of about 56,406 (298)

Adjunctive Therapeutic Plasma Exchange in Refractory Adult‐Onset Still's Disease Complicated by Secondary Macrophage Activation Syndrome: A Single‐Center Experience

Therapeutic Apheresis and Dialysis, EarlyView.
ABSTRACT Introduction Adult‐onset Still's disease (AOSD) complicated by macrophage activation syndrome (MAS) carries substantial mortality. The role of therapeutic plasma exchange (TPE) remains uncertain. Methods We retrospectively analyzed patients with AOSD‐MAS treated with TPE at a single‐center.
Masataka Ueda, Tomohiro Saito, Masahide Mizobuchi, Tomoki Shimomura, Saki Kawamori, Mitsuru Kawanishi, Natsuko Hattori, Jo Sugiyama, Satoshi Tsubata, Hanami Horiguchi, Kazuki Abe, Nao Iida, Yuki Kajio, Nao Oguro, Ryo Yanai, Hirokazu Honda   +15 more
wiley   +1 more source

Spitzer Observations of MF 16 Nebula and the associated Ultraluminous X-ray Source

, 2012
We present Spitzer Infrared Spectrograph (IRS) observations of the ultra-luminous X-ray source (ULX) NGC 6946 X-1 and its associated nebula MF 16. This ULX has very similar properties to the famous Holmberg II ULX, the first ULX to show a prominent ...
Abolmasov, Abolmasov, Berghea, Berghea, Berghea, Blair, C. T. Berghea, Carrillo, Colbert, Cseh, Dale, Dale, Dasyra, Draine, Dubner, Dudik, Dunne, Fabrika, Fridriksson, Genzel, Gliozzi, Gliozzi, Grisé, Kaaret, Kaaret, Kuncic, Lutz, Matonick, Meléndez, Miller, Mitsuda, Moon, Orosz, Pakull, R. P. Dudik, Rao, Satyapal, Shaposhnikov, Smith, Soria, Titarchuk, Tueller, Tueller, Vázquez, Weaver, Wong   +45 more
core   +1 more source

The GAPS programme with HARPS-N@TNG IV: A planetary system around XO-2S [PDF]

, 2014
We performed an intensive radial velocity monitoring of XO-2S, the wide companion of the transiting planet-host XO-2N, using HARPS-N at TNG in the framework of the GAPS programme.
Affer, L., Andreuzzi, G., Barbieri, M., Bedin, L. R., Benatti, S., Biazzo, K., Bignamini, A., Bonavita, M., Bonomo, A. S., Borsa, F., Calcidese, P., Christille, J. M., Claudi, R. U., Cosentino, R., Covino, E., Damasso, M., Desidera, S., Esposito, M., Fiorenzano, A. F. Martinez, Gandolfi, D., Giacobbe, P., Gratton, R., Harutyunyan, A., Lanza, A. F., Latham, D., Lattanzi, M., Leto, G., Lodato, G., Lovis, C., Maggio, A., Malavolta, L., Mancini, L., Marzari, F., Micela, G., Molinari, E., Mordasini, C., Munari, U., Nascimbeni, V., Pagano, I., Pedani, M., Pepe, F., Piotto, G., Poretti, E., Rainer, M., Ribas, I., Sanchez, R. Zanmar, Santos, N. C., Scandariato, G., Silvotti, R., Southworth, J., Sozzetti, A.   +50 more
core   +2 more sources

Efficacy and Safety Analysis of Roxarestat in Regulating Renal Anemia in Patients on Maintenance Hemodialysis

Therapeutic Apheresis and Dialysis, EarlyView.
ABSTRACT Objective To compare the efficacy and safety of roxarestat versus recombinant human erythropoietin (rhEPO) in the management of renal anemia in patients undergoing maintenance hemodialysis. Methods This was a prospective, open‐label, randomized controlled trial.
Lingling Chen, Junjie Zhu, Qiaonan Ge
wiley   +1 more source

The Physical Properties of the Red Supergiant WOH G64: The Largest Star Known?

, 2009
WOH G64 is an unusual red supergiant (RSG) in the Large Magellanic Cloud (LMC), with a number of properties that set it apart from the rest of the LMC RSG population, including a thick circumstellar dust torus, an unusually late spectral type, maser ...
Allen, Allen, Allsman, Bertrand Plez, Bessell, Brandner, Buchanan, Carpenter, Choi, Emily M. Levesque, Epchtein, Fluks, Gustafsson, Gustafsson, Hayashi, Humphreys, Humphreys, Hunter, Ivezić, Jaschek, Josselin, Kim, Knut A. G. Olsen, Le Sidaner, Levesque, Levesque, Levesque, Massey, Massey, Massey, Massey, Massey, Massey, Massey, Massey, Massey, Monnier, Olsen, Osterbrock, Philip Massey, Plez, Plez, Pojmanski, Roche, Schaerer, Schlegel, Schuster, Smith, van den Bergh, van Loon, van Loon, Westerlund, Westerlund   +52 more
core   +1 more source

An Observational Perspective of Transitional Disks [PDF]

, 2014
Transitional disks are objects whose inner disk regions have undergone substantial clearing. The Spitzer Space Telescope produced detailed spectral energy distributions (SEDs) of transitional disks that allowed us to infer their radial dust disk ...
Andrews, Sean, Calvet, Nuria, D'Alessio, Paola, Espaillat, Catherine, Hashimoto, Jun, Kraus, Adam, Kraus, Stefan, Muzerolle, James, Najita, Joan, Zhu, Zhaohuan   +9 more
core   +2 more sources

Effects of the Fluid Replacement Method During Online Hemodiafiltration on the Solute Removal Performance and Biocompatibility Using the Asymmetric Cellulose Triacetate Membrane

Therapeutic Apheresis and Dialysis, EarlyView.
ABSTRACT Introduction Pre‐dilution online hemodiafiltration (Pre‐HDF) is predominantly used in Japan, whereas post‐dilution online HDF (Post‐HDF) is more common in Europe. An asymmetric cellulose triacetate (ATA) membrane may improve biocompatibility.
Kenji Sakurai, Yoshitaka Kurihara, Fumi Yamauchi, Hiromi Hosoya, Takeshi Saito   +4 more
wiley   +1 more source

Reciprocal control of viral infection and phosphoinositide dynamics

FEBS Letters, EarlyView.
Phosphoinositides, although scarce, regulate key cellular processes, including membrane dynamics and signaling. Viruses exploit these lipids to support their entry, replication, assembly, and egress. The central role of phosphoinositides in infection highlights phosphoinositide metabolism as a promising antiviral target.
Marie Déborah Bancilhon, Bruno Mesmin
wiley   +1 more source

Black Hole Accretion in Transient X-Ray Binaries

, 2001
Recent work on the modes of accretion onto black holes (BHs) in Soft X-Ray Transients (SXTs) is reviewed, with an emphasis on uncertainties affecting models of accretion during quiescence (inner hot flow, outer thin disk).
Menou, Kristen
core   +3 more sources

Challenges Ahead for Companion Diagnostics [PDF]

JNCI Journal of the National Cancer Institute, 2011
T he U.S. Food and Drug Administration ’ s (FDA) approval of vemurafenib (Plexxikon/Roche) last August was greeted as a milestone not only for melanoma treatment but also for personalized medicine. The drug is indicated for patients who harbor a BRAF V600 → E mutation.
openaire   +1 more source